- Home
- EBON vs PULM Comparison
EBON vs PULM Comparison
Compare EBON & PULM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EBON
- PULM
- Stock Information
- Founded
- EBON 2010
- PULM 2003
- Country
- EBON China
- PULM United States
- Employees
- EBON N/A
- PULM N/A
- Industry
- EBON Semiconductors
- PULM Biotechnology: Pharmaceutical Preparations
- Sector
- EBON Technology
- PULM Health Care
- Exchange
- EBON Nasdaq
- PULM Nasdaq
- Market Cap
- EBON 25.3M
- PULM 20.5M
- IPO Year
- EBON 2020
- PULM N/A
- Fundamental
- Price
- EBON $4.10
- PULM $5.57
- Analyst Decision
- EBON
- PULM
- Analyst Count
- EBON 0
- PULM 0
- Target Price
- EBON N/A
- PULM N/A
- AVG Volume (30 Days)
- EBON 37.3K
- PULM 10.9K
- Earning Date
- EBON 08-22-2025
- PULM 08-12-2025
- Dividend Yield
- EBON N/A
- PULM N/A
- EPS Growth
- EBON N/A
- PULM N/A
- EPS
- EBON N/A
- PULM N/A
- Revenue
- EBON $5,868,771.00
- PULM $1,921,000.00
- Revenue This Year
- EBON N/A
- PULM N/A
- Revenue Next Year
- EBON N/A
- PULM $134.88
- P/E Ratio
- EBON N/A
- PULM N/A
- Revenue Growth
- EBON 20.88
- PULM N/A
- 52 Week Low
- EBON $3.00
- PULM $1.78
- 52 Week High
- EBON $10.94
- PULM $10.40
- Technical
- Relative Strength Index (RSI)
- EBON 44.68
- PULM 36.25
- Support Level
- EBON $4.25
- PULM $5.20
- Resistance Level
- EBON $5.10
- PULM $6.15
- Average True Range (ATR)
- EBON 0.34
- PULM 0.30
- MACD
- EBON -0.08
- PULM -0.05
- Stochastic Oscillator
- EBON 7.14
- PULM 22.70
About EBON Ebang International Holdings Inc.
Ebang International Holdings Inc is a blockchain technology and Fintech company, that has ASIC chip design capability. Its business is ASIC chip design and Telecommunication. It operates in a single segment selling bitcoin mining machines and related accessories, telecommunication products, providing cryptocurrency exchange services, management and maintenance services, and cross-border payment and foreign exchange services and rental services. Its geographic regions are Mainland China, and Australia.
About PULM Pulmatrix Inc.
Pulmatrix Inc is a biopharmaceutical company that has focused on the development of novel inhaled therapeutic products intended to prevent and treat migraine and respiratory diseases with important unmet medical needs using its patented dry powder delivery technology, iSPERSE. Its pipeline of clinical assets includes PUR3100 for the treatment of acute migraine, PUR1800 for the treatment of acute exacerbations of chronic obstructive pulmonary disease (AECOPD), and PUR1900 for the treatment of ABPA in patients with asthma and in patients with cystic fibrosis (CF).